Transcriptional factor NF-κb as a target for therapy in Parkinson's disease

Parkinson's Disease

Volumn , Issue , 2011, Pages

  Flood, Patrick M ^a   Qian, Li ^a   Peterson, Lynda J ^a   Zhang, Feng ^b,c   Shi, Jing Shan ^b   Gao, Hui Ming ^c   Hong, Jau Shyong ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Zunji Medical College   (China)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 6 CHLORO 8 NICOTINAMIDO BETA CARBOLINE; BAY 651942; CURCUMIN; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MORPHINAN DERIVATIVE; NITRIC OXIDE; OXIDOPAMINE; PARKIN; PIOGLITAZONE; PROTEIN P50; SALMETEROL; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; DRUG TARGETING; DUCHENNE MUSCULAR DYSTROPHY; ENCEPHALOMYELITIS; ENTERITIS; GRAFT VERSUS HOST REACTION; HUMAN; IN VITRO STUDY; IN VIVO CULTURE; MICROGLIA; MOTOR PERFORMANCE; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 79959272144     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.4061/2011/216298     Document Type: Review

References (105)

1. Block M. L., Hong J. S., Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism Progress in Neurobiology 2005 76 2 77 98 (Pubitemid 41242883)
2. Bartels A. L., Leenders K. L., Neuroinflammation in the pathophysiology of Parkinson's disease: evidence from animal models to human in vivo studies with [C]-PK11195 PET Movement Disorders 2007 22 13 1852 1856 (Pubitemid 350134195)
3. Dauer W., Przedborski S., Parkinson's disease: mechanisms and models Neuron 2003 39 6 889 909 (Pubitemid 37130207)
4. Gao H. M., Hong J. S., Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression Trends in Immunology 2008 29 8 357 365
5. McGeer P. L., Itagaki S., Boyes B. E., McGeer E. G., Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains Neurology 1988 38 8 1285 1291
6. Nagatsu T., Mogi M., Ichinose H., Togari A., Changes in cytokines and neurotrophins in Parkinson's disease Journal of Neural Transmission 2000 60, supplement 277 290 (Pubitemid 32037200)
7. Mogi M., Harada M., Kondob T., Riederer P., Inagaki H., Minami M., Nagatsu T., Interleukin-1, interleukin-6, epidermal growth factor and transforming growth factor- are elevated in the brain from parkinsonian patients Neuroscience Letters 1994 180 2 147 150
8. Ouchi Y., Yagi S., Yokokura M., Sakamoto M., Neuroinflammation in the living brain of Parkinson's disease Parkinsonism and Related Disorders 2009 15 3 S200 S204
9. Qureshi G. A., Baig S., Bednar I., Sodersten P., Forsberg G., Siden A., Increased cerebrospinal fluid concentration of nitrite ire Parkinson's disease NeuroReport 1995 6 12 1642 1644
10. Hunot S., Boissire F., Faucheux B., Brugg B., Mouatt-Prigent A., Agid Y., Hirsch E. C., Nitric oxide synthase and neuronal vulnerability in Parkinson's disease Neuroscience 1996 72 2 355 363 (Pubitemid 26111202)
11. Qian L., Flood P. M., Microglial cells and Parkinson's disease Immunologic Research 2008 41 3 155 164
12. McCoy M. K., Tansey M. G., TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease Journal of Neuroinflammation 2008 5, article 45
13. Jenner P., Oxidative mechanisms in nigral cell death in Parkinson's disease Movement Disorders 1998 13 supplement 1 24 34
14. Zielasek J., Hartung H. P., Molecular mechanisms of microglial activation Advances in Neuroimmunology 1996 6 2 191 222 (Pubitemid 26279977)
15. Rogers J., Lue L. F., Microglial chemotaxis, activation, and phagocytosis of amyloid -peptide as linked phenomena in Alzheimer's disease Neurochemistry International 2001 39 5-6 333 340 (Pubitemid 32907397)
16. Frank-Cannon T. C., Tran T., Ruhn K. A., Martinez T. N., Hong J., Marvin M., Hartley M., Trevio I., O'Brien D. E., Casey B., Goldberg M. S., Tansey M. G., Parkin deficiency increases vulnerability to inflammation-related nigral degeneration Journal of Neuroscience 2008 28 43 10825 10834
17. Reynolds A. D., Glanzer J. G., Kadiu I., Ricardo-Dukelow M., Chaudhuri A., Ciborowski P., Cerny R., Gelman B., Thomas M. P., Mosley R. L., Gendelman H. E., Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease Journal of Neurochemistry 2008 104 6 1504 1525 (Pubitemid 351316759)
18. Hirsch E. C., Hunot S., Hartmann A., Neuroinflammatory processes in Parkinson's disease Parkinsonism and Related Disorders 2005 11 1 S9 S15
19. Wilms H., Zecca L., Rosenstiel P., Sievers J., Deuschl G., Lucius R., Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications Current Pharmaceutical Design 2007 13 18 1925 1928 (Pubitemid 47017994)
20. McGeer P. L., Schwab C., Parent A., Doudet D., Presence of reactive microglia in monkey Substantia nigra years after 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine administration Annals of Neurology 2003 54 5 599 604 (Pubitemid 37346066)
21. Cicchetti F., Brownell A. L., Williams K., Chen Y. I., Livni E., Isacson O., Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging European Journal of Neuroscience 2002 15 6 991 998 (Pubitemid 35463634)
22. Meissner W., Prunier C., Guilloteau D., Chalon S., Gross C. E., Bezard E., Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease Molecular Neurobiology 2003 28 3 209 218 (Pubitemid 38156419)
23. Ebert A. D., Hoo J. H., Bohn M. C., Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of Parkinson's disease does not involve activation of caspase-9 and caspase-3 Journal of Neuroscience Research 2008 86 2 317 325 (Pubitemid 351196737)
24. Simard A. R., Rivest S., Do pathogen exposure and innate immunity cause brain diseases? Neurological Research 2005 27 7 717 725 (Pubitemid 41513080)
25. Ransohoff R. M., Perry V. H., Microglial physiology: unique stimuli, specialized responses Annual Review of Immunology 2009 27 119 145
26. Brown G. C., Neher J. J., Inflammatory neurodegeneration and mechanisms of microglial killing of neurons Molecular Neurobiology 2010 41 2-3 242 247
27. Mogi M., Harada M., Riederer P., Narabayashi H., Fujita K., Nagatsu T., Tumor necrosis factor- (TNF- ) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients Neuroscience Letters 1994 165 1-2 208 210
28. Arai H., Furuya T., Yasuda T., Miura M., Mizuno Y., Mochizuki H., Neurotoxic effects of lipopolysaccharide on nigral dopaminergic neurons are mediated by microglial activation, interleukin-1, and expression of caspase-11 in mice Journal of Biological Chemistry 2004 279 49 51647 51653 (Pubitemid 40017915)
29. Caudle W. M., Zhang J., Glutamate, excitotoxicity, and programmed cell death in parkinson disease Experimental Neurology 2009 220 2 230 233
30. Choi D. W., Glutamate neurotoxicity and diseases of the nervous system Neuron 1988 1 8 623 634
31. Thirumangalakudi L., Yin L., Rao H. V., Grammas P., IL-8 induces expression of matrix metalloproteinases, cell cycle and pro-apoptotic proteins, and cell death in cultured neurons Journal of Alzheimer's Disease 2007 11 3 305 311 (Pubitemid 47094028)
32. Loeffler D. A., DeMaggio A. J., Juneau P. L., Havaich M. K., LeWitt P. A., Effects of enhanced striatal dopamine turnover in vivo on glutathione oxidation Clinical Neuropharmacology 1994 17 4 370 379 (Pubitemid 24239388)
33. Imamura K., Hishikawa N., Sawada M., Nagatsu T., Yoshida M., Hashizume Y., Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains Acta Neuropathologica 2003 106 6 518 526 (Pubitemid 37441607)
34. Barcia C., De Pablos V., Bautista-Hernndez V., Snchez-Bahillo., Bernal I., Fernndez-Villalba E., Martn J., Ban R., Fernndez-Barreiro A., Herrero M. T., Increased plasma levels of TNF- but not of IL1- in MPTP-treated monkeys one year after the MPTP administration Parkinsonism and Related Disorders 2005 11 7 435 439 (Pubitemid 41526994)
35. Sen R., Baltimore D., Multiple nuclear factors interact with the immunoglobulin enhancer sequences Cell 1986 46 5 705 716 (Pubitemid 16020062)
36. Sen R., Baltimore D., Inducibility of K immunoglobulin enhancer-binding protein NF- B by a posttranslational mechanism Cell 1986 47 6 921 928 (Pubitemid 17005065)
37. Tsoulfas G., Geller D. A., NF- B in transplantation: friend or foe? Transplant Infectious Disease 2001 3 4 212 219
38. Roebuck K. A., Regulation of interleukin-8 gene expression Journal of Interferon and Cytokine Research 1999 19 5 429 438 (Pubitemid 29269932)
39. Xia Y., Pauza M. E., Feng L., Lo D., RelB regulation of chemokine expression modulates local inflammation American Journal of Pathology 1997 151 2 375 387 (Pubitemid 27330058)
40. Roebuck K. A., Carpenter L. R., Lakshminarayanan V., Page S. M., Moy J. N., Thomas L. L., Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF- B Journal of Leukocyte Biology 1999 65 3 291 298 (Pubitemid 29109699)
41. Lawrence T., The nuclear factor NF-kappaB pathway in inflammation Cold Spring Harbor Perspectives in Biology 2009 1 6, article a001651
42. Gauss K. A., Nelson-Overton L. K., Siemsen D. W., Gao Y., DeLeo F. R., Quinn M. T., Role of NF- B in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor- Journal of Leukocyte Biology 2007 82 3 729 741 (Pubitemid 47367165)
43. Chen C. C., Manning A. M., Transcriptional regulation of endothelial cell adhesion molecules: a dominant role for NF- B Agents and Actions Supplements 1995 47 135 141
44. Tak P. P., Firestein G. S., NF- B: a key role in inflammatory diseases Journal of Clinical Investigation 2001 107 1 7 11
45. Van der Heiden K., Cuhlmann S., Luong A., Zakkar M., Evans P. C., Role of nuclear factor kappaB in cardiovascular health and disease Clinical Science 2010 118 10 593 605
46. Latanich C. A., Toledo-Pereyra L. H., Searching for NF- B-based treatments of ischemia reperfusion injury Journal of Investigative Surgery 2009 22 4 301 315
47. Vandenbroeck K., Alloza I., Gadina M., Matthys P., Inhibiting cytokines of the interleukin-12 family: recent advances and novel challenges Journal of Pharmacy and Pharmacology 2004 56 2 145 160 (Pubitemid 38232744)
48. Criswell L. A., Gene discovery in rheumatoid arthritis highlights the CD40/NF- B signaling pathway in disease pathogenesis Immunological Reviews 2010 233 1 55 61
49. Atreya I., Atreya R., Neurath M. F., NF- B in inflammatory bowel disease Journal of Internal Medicine 2008 263 6 591 596
50. Lawrence T., Fong C., The resolution of inflammation: anti-inflammatory roles for NF- B International Journal of Biochemistry and Cell Biology 2010 42 4 519 523
51. Pereira S. G., Oakley F., Nuclear factor- B1: regulation and function International Journal of Biochemistry and Cell Biology 2008 40 8 1425 1430
52. Wang M. S., Boddapati S., Emadi S., Sierks M. R., Curcumin reduces -synuclein induced cytotoxicity in Parkinson's disease cell model BMC Neuroscience 2010 11, article 57
53. Huxford T., Ghosh G., A structural guide to proteins of the NF-kappaB signaling module Cold Spring Harbor Perspectives in Biology 2009 1 3, article a000075
54. Oeckinghaus A., Ghosh S., The NF-kappaB family of transcription factors and its regulation Cold Spring Harbor Perspectives in Biology 2009 1 4, article a000034
55. May M. J., Marienfeld R. B., Ghosh S., Characterization of the I B-kinase NEMO binding domain Journal of Biological Chemistry 2002 277 48 45992 46000 (Pubitemid 35417584)
56. Sizemore N., Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B The Journal of Biological Chemistry 2002 277 6 3863 3869 (Pubitemid 34968637)
57. Sizemore N., Agarwal A., Das K., Lerner N., Sulak M., Rani S., Ransohoff R., Shultz D., Stark G. R., Inhibitor of B kinase is required to activate a subset of interferon -stimulated genes Proceedings of the National Academy of Sciences of the United States of America 2004 101 21 7994 7998 (Pubitemid 38698042)
58. Reuther-Madrid J. Y., Kashatus D., Chen S., Li X., Westwick J., Davis R. J., Earp H. S., Wang C. Y., Baldwin A. S., The p65/RelA subunit of NF- B suppresses the sustained, antiapoptotic activity of Jun kinase induced by tumor necrosis factor Molecular and Cellular Biology 2002 22 23 8175 8183 (Pubitemid 35304051)
59. Rudolph D., Yeh W. C., Wakeham A., Rudolph B., Nallainathan D., Potter J., Elia A. J., Mak T. W., Severe liver degeneration and lack of NF- B activation in NEMO/IKK -deficient mice Genes and Development 2000 14 7 854 862 (Pubitemid 30215004)
60. Xia Z. P., Chen Z. J., TRAF2: a double-edged sword? Science's STKE 2005 2005 272 e7
61. Neumann M., Naumann M., Beyond I Bs: alternative regulation of NF- B activity FASEB Journal 2007 21 11 2642 2654
62. Brown K. D., Claudio E., Siebenlist U., The roles of the classical and alternative nuclear factor- B pathways: potential implications for autoimmunity and rheumatoid arthritis Arthritis Research and Therapy 2008 10 4, article 212
63. Israel A., The IKK complex, a central regulator of NF-kappaB activation Cold Spring Harbor Perspectives in Biology 2010 2 3, article a000158
64. Bakkar N., Guttridge D. C., NF- B signaling: a tale of two pathways in skeletal myogenesis Physiological Reviews 2010 90 2 495 511
65. Pomerantz J. L., Baltimore D., Two pathways to NF- B Molecular Cell 2002 10 4 693 695
66. Yamamoto Y., Verma U. N., Prajapati S., Youn-Tae K., Gaynor R. B., Histone H3 phosphorylation by ikk- is critical for cytokine-induced gene expression Nature 2003 423 6940 655 659 (Pubitemid 36713227)
67. Anest V., Hanson J. L., Cogswell P. C., Steinbrecher K. A., Strahl B. D., Baldwin A. S., A nucleosomal function for I B kinase- in NF- B-dependent gene expression Nature 2003 423 6940 659 663 (Pubitemid 36713228)
68. Sil A. K., Maeda S., Sono Y., Roop D. B., Karin M., I B kinase- acts in the epidermis to control skeletal and craniofacial morphogenesis Nature 2004 428 6983 660 664 (Pubitemid 38524809)
69. Gareus R., Huth M., Breiden B., Nenci A., Rsch N., Haase I., Bloch W., Sandhoff K., Pasparakis M., Normal epidermal differentiation but impaired skin-barrier formation upon keratinocyte-restricted IKK1 ablation Nature Cell Biology 2007 9 4 461 469 (Pubitemid 46511080)
70. Dahlman J. M., Bakkar N., He W., Guttridge D. C., NF- B functions in stromal fibroblasts to regulate early postnatal muscle development Journal of Biological Chemistry 2010 285 8 5479 5487
71. Bakkar N., Wang J., Ladner K. J., Wang H., Dahlman J. M., Carathers M., Acharyya S., Rudnicki M. A., Hollenbach A. D., Guttridge D. C., IKK/NF- B regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis Journal of Cell Biology 2008 180 4 787 802 (Pubitemid 351397778)
72. Xue Y., Wang X., Li Z., Gotoh N., Chapman D., Skolnik E. Y., Mesodermal patterning defect in mice lacking the Ste20 NCK interacting kinase (NIK) Development 2001 128 9 1559 1572 (Pubitemid 32514840)
73. Soysa N. S., Alles N., Weih D., Lovas A., Hussain Mian A., Shimokawa H., Yasuda H., Weih F., Jimi E., Ohya K., Aoki K., The pivotal role of the alternative NF- B pathway in maintenance of basal bone homeostasis and osteoclastogenesis Journal of Bone and Mineral Research 2010 25 4 809 818
74. Mogi M., Kondo T., Mizuno Y., Nagatsu T., p53 protein, interferon-, and NF- B levels are elevated in the parkinsonian brain Neuroscience Letters 2007 414 1 94 97 (Pubitemid 46241643)
75. Hunot S., Brugg B., Ricard D., Michel P. P., Muriel M. P., Ruberg M., Faucheux B. A., Agid Y., Hirsch E. C., Nuclear translocation of NF- b is increased in dopaminergic neurons of patients with Parkinson disease Proceedings of the National Academy of Sciences of the United States of America 1997 94 14 7531 7536 (Pubitemid 27345350)
76. Cao J. P., Wang H. J., Yu J. K., Liu H. M., Gao D. S., The involvement of NF- B p65/p52 in the effects of GDNF on DA neurons in early PD rats Brain Research Bulletin 2008 76 5 505 511
77. May M. J., D'Acquisto F., Madge L. A., Glockner J., Pober J. S., Ghosh S., Selective inhibition of NF- B activation by a peptide that blocks the interaction of NEMO with the I B kinase complex Science 2000 289 5484 1550 1554
78. Di Meglio P., Ianaro A., Ghosh S., Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF- B activation Arthritis and Rheumatism 2005 52 3 951 958 (Pubitemid 40365119)
79. Jimi E., Aoki K., Saito H., D'Acquisto F., May M. J., Nakamura I., Sudo T., Kojima T., Okamoto F., Fukushima H., Okabe K., Ohya K., Ghosh S., Selective inhibition of NF- B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo Nature Medicine 2004 10 6 617 624 (Pubitemid 38796853)
80. Dai S., Hirayama T., Abbas S., Abu-Amer Y., The I B kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis Journal of Biological Chemistry 2004 279 36 37219 37222 (Pubitemid 39195425)
81. Dav S. H., Tilstra J. S., Matsuoka K., Li F., Karrasch T., Uno J. K., Sepulveda A. R., Jobin C., Baldwin A. S., Robbins P. D., Plevy S. E., Amelioration of chronic murine colitis by peptide-mediated transduction of the I B kinase inhibitor NEMO binding domain peptide Journal of Immunology 2007 179 11 7852 7859
82. Desai A., Singh N., Raghubir R., Neuroprotective potential of the NF-[kappa]B inhibitor peptide IKK-NBD in cerebral ischemia-reperfusion injury Neurochemistry International 2010 57 8 876 883
83. Grassia G., The I{kappa}B kinase inhibitor nuclear factor-{kappa}B essential modulator-binding domain peptide for inhibition of balloon injury-induced neointimal formation Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 12 2458 2466
84. Moss N. C., Stansfield W. E., Willis M. S., Tang R. H., Selzman C. H., IKK inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury American Journal of Physiology 2007 293 4 H2248 H2253
85. Zhang F., Qian L., Flood P. M., Shi J. S., Hong J. S., Gao H. M., Inhibition of I B kinase- protects dopamine neurons against lipopolysaccharide- induced neurotoxicity Journal of Pharmacology and Experimental Therapeutics 2010 333 3 822 833
86. Ziegelbauer K., Gantner F., Lukacs N. W., Berlin A., Fuchikami K., Niki T., Sakai K., Inbe H., Takeshita K., Ishimori M., Komura H., Murata T., Lowinger T., Bacon K. B., A selective novel low-molecular-weight inhibitor of I B kinase- (IKK- ) prevents pulmonary inflammation and shows broad anti-inflammatory activity British Journal of Pharmacology 2005 145 2 178 192 (Pubitemid 40756522)
87. Hideshima T., Chauhan D., Richardson P., Mitsiades C., Mitsiades N., Hayashi T., Munshi N., Dang L., Castro A., Palombella V., Adams J., Anderson K. C., NF- B as a therapeutic target in multiple myeloma Journal of Biological Chemistry 2002 277 19 16639 16647
88. Podolin P. L., Callahan J. F., Bolognese B. J., Li Y. H., Carlson K., Davis T. G., Mellor G. W., Evans C., Roshak A. K., Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of I B kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)- 3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell proliferation Journal of Pharmacology and Experimental Therapeutics 2005 312 1 373 381 (Pubitemid 40096491)
89. O'Shaughnessy M. J., Vogtenhuber C., Sun K., Sitcheran R., Baldwin A. S., Murphy W. J., Dang L., Jaffee B., Palmer E., Serody J. S., Blazar B. R., Ex vivo inhibition of NF- B signaling in alloreactive T-cells prevents graft-versus-host disease American Journal of Transplantation 2009 9 3 452 462
90. Hideshima T., Hayashi T., Chauhan D., Akiyama M., Richardson P., Anderson K., Biologic sequelae of c-Jun NH-terminal kinase (JNK) activation in multiple myeloma cell lines Oncogene 2003 22 54 8797 8801 (Pubitemid 38010503)
91. Yang J., Conditional ablation of Ikkb inhibits melanoma tumor development in mice The Journal of Clinical Investigation 2010 120 7 2563 2574
92. Schn M., Wienrich B. G., Kneitz S., Sennefelder H., Amschler K., Vhringer V., Weber O., Stiewe T., Ziegelbauer K., Schn M. P., KINK-1, a novel small-molecule inhibitor of IKK, and the susceptibility of melanoma cells to antitumoral treatment Journal of the National Cancer Institute 2008 100 12 862 875 (Pubitemid 351881954)
93. Amschler K., Schn M. P., Pletz N., Wallbrecht K., Erpenbeck L., Schn M., NF- B inhibition through proteasome inhibition or ikk blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways Journal of Investigative Dermatology 2010 130 4 1073 1086
94. Yemelyanov A., Gasparian A., Lindholm P., Dang L., Pierce J. W., Kisseljov F., Karseladze A., Budunova I., Effects of IKK inhibitor PS1145 on NF- B function, proliferation, apoptosis and invasion activity in prostate carcinoma cells Oncogene 2006 25 3 387 398 (Pubitemid 43117624)
95. Moore K. W., De Waal Malefyt R., Coffman R. L., O'Garra A., Interleukin-10 and the interleukin-10 receptor Annual Review of Immunology 2001 19 683 765 (Pubitemid 32368050)
96. Strle K., Zhou J. H., Shen W. H., Broussard S. R., Johnson R. W., Freund G. G., Dantzer R., Kelley K. W., Interleukin-10 in the brain Critical Reviews in Immunology 2001 21 5 427 449 (Pubitemid 34259914)
97. Zhu Y., Yang G. Y., Ahlemeyer B., Pang L., Che X. M., Culmsee C., Klumpp S., Krieglstein J., Transforming growth factor-β1 increases bad phosphorylation and protects neurons against damage Journal of Neuroscience 2002 22 10 3898 3909 (Pubitemid 37465698)
98. Szczepanik M., Tutaj M., Bryniarski K., Dittel B. N., Epicutaneously induced TGF- -dependent tolerance inhibits experimental autoimmune encephalomyelitis Journal of Neuroimmunology 2005 164 1-2 105 114 (Pubitemid 40826767)
99. Zhang W., Hong J. S., Kim H. C., Zhang W., Block M. L., Morphinan neuroprotection: new insight into the therapy of neurodegeneration Critical Reviews in Neurobiology 2004 16 4 271 302 (Pubitemid 40781083)
100. Qian L., NADPH oxidase inhibitor DPI is neuroprotective at femtomolar concentrations through inhibition of microglia over-activation Parkinsonism and Related Disorders 2007 13 supplement 3 S316 S320
101. Qian L., Flood P. M., Hong J. S., Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy Journal of Neural Transmission 2010 117 8 971 979
102. Yang S., Zhang D., Yang Z., Hu X., Qian S., Liu J., Wilson B., Block M., Hong J. S., Curcumin protects dopaminergic neuron against LPS induced neurotoxicity in primary rat neuron/glia culture Neurochemical Research 2008 33 10 2044 2053
103. Qian L., Wu H. -M., Chen S. -H., Zhang D., Peterson L. J., Wilson B., Lu R. -B., Hong J. -S., Flood P. M., 2-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway Journal of Immunology 2011 186 7 4443 4454
104. Ghosh A., Roy A., Liu X., Kordower J. H., Mufson E. J., Hartley D. M., Ghosh S., Mosley R. L., Gendelman H. E., Pahan K., Selective inhibition of NF- B activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 2007 104 47 18754 18759 (Pubitemid 350210769)
105. Zhang F., Qian L., Flood P. M., Shi J. S., Hong J. S., Gao H. M., Inhibition of I B kinase- protects dopamine neurons against lipopolysaccharide- induced neurotoxicity Journal of Pharmacology and Experimental Therapeutics 2010 333 3 822 833